Liver samples were stained with hematoxylin and eosin and imaged at 4x. by Bryan S. Margulies (21492667)

Subjects:

Bioluminescent Doubling Time. by Bryan S. Margulies (21492667)

Subjects:

Study Design. by Bryan S. Margulies (21492667)

Subjects:

Liver weights were normalized by the mouse body weight to derive the %liver weight. by Bryan S. Margulies (21492667)

Subjects:

Histomorphometric analysis of the tumor volume fraction (V_f) in the liver and necrosis volume fraction. by Bryan S. Margulies (21492667)

Subjects:

(A) Release rate (i.e., elution) of N-allyl noroxymorphone hydrochloride evaluated using UPLC from two samples of MBC-005. The equations predict that at 24-hours there will be betw... by Bryan S. Margulies (21492667)

Subjects:

The MTT assay and the LDH assay were used to assess the effects of the hydrogel component of MBC-005 on tumor cell number and cell death. by Bryan S. Margulies (21492667)

Subjects:

The spheroid assay is used to assess long-term effects of therapy on tumor cell by culturing the tumor cells in a micro-mass, which is a 3D tumor mass used as a surrogate for in vi... by Bryan S. Margulies (21492667)

Subjects:

Survival in mice with liver metastases after MBC-005 TREATMENT. by Bryan S. Margulies (21492667)

Subjects:

Inhibitor versus the normalized dose response curves. by Bryan S. Margulies (21492667)

Subjects:

Viscosity assessed using a tuning-fork viscometer. by Bryan S. Margulies (21492667)

Subjects:

Interpolated survival in mice with or without lung metastases. by Bryan S. Margulies (21492667)

Subjects:

The p21 ELISA assay was used to assess the effects of MBC-005 on tumor cell expression of p21. by Bryan S. Margulies (21492667)

Subjects:

Ictogenic changes in input correlation and adaptation gains are associated with increased dynamical variability during baseline activity. by Scott Rich (9873638)

“…<b>B</b>: <i>U</i>_<i>e</i> and <i>U</i>_<i>i</i> Normalized SD during baseline activity (top) and SLE rate (bottom) in the default model compared to two non-ictogenic scenarios— decreased from 50.0 to 40.0 and decreased from 1.2 to .8. …”

S1 Data - by Bowen Deng (3123237)

“…</p><p>Results</p><p>Among 1,523 eligible patients, 227 (14.9%) died within 30 days. We identified 4 longitudinal trajectories of blood glucose, including class 1 (a low initial average blood glucose level with steady trend within 24 hours), class 2 (a high initial average blood glucose with gently decreased trend), class 3 (the highest initial average blood glucose with rapidly decreased trend) and class 4 (a high initial average blood glucose level with the trend that increased at first and then decreased). …”

Characteristics of AMI patients with DM. by Bowen Deng (3123237)

“…</p><p>Results</p><p>Among 1,523 eligible patients, 227 (14.9%) died within 30 days. We identified 4 longitudinal trajectories of blood glucose, including class 1 (a low initial average blood glucose level with steady trend within 24 hours), class 2 (a high initial average blood glucose with gently decreased trend), class 3 (the highest initial average blood glucose with rapidly decreased trend) and class 4 (a high initial average blood glucose level with the trend that increased at first and then decreased). …”

Baseline characteristics of participants for changes in frailty status analyses. by Xiaohan Gan (22097061)

Subjects:

Association of changes in frailty status with risks of Urinary Incontinence. by Xiaohan Gan (22097061)

Subjects:

Changes in gut microbial taxa (Genus level)pre- and post-surgery. by Manal Ali Ahmad (16868808)

Subjects:

Demographics, anthropometrics, and biochemical parameters between pre- and post-bariatric surgery (n = 19). by Manal Ali Ahmad (16868808)

Subjects: